Evolus & Urovant: Similar Strategies, Opposite Reactions to Positive Catalysts
One of the strongest performing biopharmaceutical stocks this year is [...]
Call Us: (800) 891-1526
M - F 8AM to 4PM ET
Recro To Consider Dispute Resolution With FDA After Complete Response Letter
Shares of Recro Pharma, Inc. (NASDAQ:REPH) likely will fall in [...]